Name | Datelliptium chloride hydrochloride |
---|
Description | Datelliptium chloride hydrochloride is a DNA-intercalating agent derived from Ellipticine (HY-15753). Datelliptium chloride hydrochloride is effective in vivo against a variety of murine solid tumors[1][2]. |
---|---|
Related Catalog | |
In Vitro | Datelliptium chloride hydrochloride shows cytotoxic effects after 2 hours of treatment in suspension and primary cultures of rat hepatocytes[1]. |
In Vivo | Datelliptium chloride hydrochloride has broad antitumor activity against solid tumors of mice in vivo[2]. Datelliptium chloride hydrochloride (170 mg/kg; i.v; for 12 days) exhibits a high degree of antitumor activity at early staged disease[2]. Datelliptium chloride hydrochloride is selectively cytotoxic for solid tumors over leukemia L1210[2]. Animal Model: Mice, colon adenocarcinoma early staged disease model[2] Dosage: 170 mg/kg Administration: Intravenous injection, for 12 days Result: Highly active against colon adenocarcinoma. |
References |
Molecular Formula | C23H29Cl2N3O |
---|---|
Molecular Weight | 434.40 |